These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Compatibility considerations in parenteral nutrient solutions. Niemiec PW; Vanderveen TW Am J Hosp Pharm; 1984 May; 41(5):893-911. PubMed ID: 6328980 [TBL] [Abstract][Full Text] [Related]
48. The stability of parenteral fat emulsions in nutrition mixtures. du Plessis J; van Wyk CJ; Ackermann C J Clin Pharm Ther; 1987 Oct; 12(5):307-18. PubMed ID: 3119608 [TBL] [Abstract][Full Text] [Related]
49. Effect of the intravenous lipid emulsions on the availability of calcium when using organic phosphate in TPN admixtures. Chaieb D S; Chaumeil JC; Jebnoun S; Khrouf N; Hedhili A; Sfar S Pharm Res; 2008 Nov; 25(11):2545-54. PubMed ID: 18719980 [TBL] [Abstract][Full Text] [Related]
50. [Comparison of dextrose-TPN and dextrose-lipid-TPN in surgical patients]. Wu ZG; Wu ZH; Yuan XQ Zhonghua Wai Ke Za Zhi; 1985 Feb; 23(2):65-8, 125. PubMed ID: 3921324 [No Abstract] [Full Text] [Related]
51. Historical aspects of minerals and vitamins in parenteral nutrition. Shils ME Fed Proc; 1984 Apr; 43(5):1412-6. PubMed ID: 6423411 [TBL] [Abstract][Full Text] [Related]
52. Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs. Staven V; Wang S; Grønlie I; Tho I Nutr J; 2016 Mar; 15():29. PubMed ID: 27000057 [TBL] [Abstract][Full Text] [Related]
53. Variations in metabolic response to TPN are influenced more by sex than by light exposure. Harrison A; Khashu M; Friel J; Lavoie JC; Chessex P J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):577-81. PubMed ID: 18030236 [TBL] [Abstract][Full Text] [Related]
54. [Amphotericin B into parenteral lipid emulsions. Galenic stability of mixtures. Preliminary results]. Blancard A; Monges P; Lacarelle B; Denis JP; Bongrand MC; Ragon CH; Gouin F Pathol Biol (Paris); 1996 May; 44(5):384-8. PubMed ID: 8758481 [TBL] [Abstract][Full Text] [Related]
55. [Total and prolonged parenteral nutrition at the hospital and at the patient's home: its socio-economic importance]. Joyeux H; Gouttebel MC Bull Acad Natl Med; 1995 Nov; 179(8):1625-36. PubMed ID: 8717180 [TBL] [Abstract][Full Text] [Related]
56. Effect of coadministration of parenteral multivitamins with lipid emulsion on lung remodeling in an animal model of total parenteral nutrition. Lavoie JC; Rouleau T; Chessex P Pediatr Pulmonol; 2005 Jul; 40(1):53-6. PubMed ID: 15858798 [TBL] [Abstract][Full Text] [Related]
57. Container effects on the physicochemical properties of parenteral lipid emulsions. Gonyon T; Carter PW; Dahlem O; Denet AR; Owen H; Trouilly JL Nutrition; 2008; 24(11-12):1182-8. PubMed ID: 18707847 [TBL] [Abstract][Full Text] [Related]
58. Clinical significance of providing medium-chain triglyceride (MCT) in total parenteral nutrition (TPN). Sultan F Nutrition; 1995; 11(1):51-2. PubMed ID: 7749247 [No Abstract] [Full Text] [Related]
59. Tracking of the kinetic stability of 2 types of total nutrient admixtures containing different lipid emulsions. Balogh J; Kiss D; Dredán J; Puskás I; Csempesz F; Zelkó R AAPS PharmSciTech; 2006; 7(4):98. PubMed ID: 17285747 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of physical stability of all in one parenteral admixtures for pediatric home care with high electrolytes concentrations. Watrobska-Swietlikowska D; Szlagatys-Sidorkiewicz A; Łuszkiewicz K Nutr Hosp; 2014 Jan; 31(1):236-43. PubMed ID: 25561115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]